###begin article-title 0
MiRNA-Directed Regulation of VEGF and Other Angiogenic Factors under Hypoxia
###end article-title 0
###begin p 1
Conceived and designed the experiments: ZH QL WY YZ. Performed the experiments: ZH QL WY DG YJ. Analyzed the data: BY YZ GC JW CW CZ. Wrote the paper: BY YZ CW.
###end p 1
###begin p 2
###xml 404 409 <span type="species:ncbi:9606">human</span>
MicroRNAs (miRNAs) are a class of 20-24 nt non-coding RNAs that regulate gene expression primarily through post-transcriptional repression or mRNA degradation in a sequence-specific manner. The roles of miRNAs are just beginning to be understood, but the study of miRNA function has been limited by poor understanding of the general principles of gene regulation by miRNAs. Here we used CNE cells from a human nasopharyngeal carcinoma cell line as a cellular system to investigate miRNA-directed regulation of VEGF and other angiogenic factors under hypoxia, and to explore the principles of gene regulation by miRNAs. Through computational analysis, 96 miRNAs were predicted as putative regulators of VEGF. But when we analyzed the miRNA expression profile of CNE and four other VEGF-expressing cell lines, we found that only some of these miRNAs could be involved in VEGF regulation, and that VEGF may be regulated by different miRNAs that were differentially chosen from 96 putative regulatory miRNAs of VEGF in different cells. Some of these miRNAs also co-regulate other angiogenic factors (differential regulation and co-regulation principle). We also found that VEGF was regulated by multiple miRNAs using different combinations, including both coordinate and competitive interactions. The coordinate principle states that miRNAs with independent binding sites in a gene can produce coordinate action to increase the repressive effect of miRNAs on this gene. By contrast, the competitive principle states when multiple miRNAs compete with each other for a common binding site, or when a functional miRNA competes with a false positive miRNA for the same binding site, the repressive effects of miRNAs may be decreased. Through the competitive principle, false positive miRNAs, which cannot directly repress gene expression, can sometimes play a role in miRNA-mediated gene regulation. The competitive principle, differential regulation, multi-miRNA binding sites, and false positive miRNAs might be useful strategies in the avoidance of unwanted cross-action among genes targeted by miRNAs with multiple targets.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 359 362 359 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000116-Bartel1">[1]</xref>
###xml 363 366 363 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000116-Nakahara1">[4]</xref>
###xml 505 508 505 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000116-Mallory1">[5]</xref>
###xml 509 513 509 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000116-Johnson1">[11]</xref>
MicroRNAs (miRNAs) were discovered over a decade ago but only in recent years have they been recognized as one of the major regulatory gene families in cells. As a new family of small non-coding RNA molecules with approximately 22 nucleotides, miRNAs regulate gene expression through translational repression or mRNA degradation in a sequence-specific manner [1]-[4]. They are known to be involved in gene functioning during development, cell proliferation, apoptosis, differentiation, and carcinogenesis [5]-[11]. MiRNA functional identification has become one of the most active research fields in biology.
###end p 4
###begin p 5
###xml 397 401 397 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000116-Enright1">[12]</xref>
###xml 402 406 402 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000116-Rehmsmeier1">[19]</xref>
However, the study on miRNA function has been limited by several obstacles. In addition to the difficulty of accurately predicting their targets and validating these findings, poor understanding of the general principles of gene regulation by miRNAs is a major obstacle. Recently, with the development of new computational algorithms, more and more targets regulated by miRNAs have been predicted [12]-[19]. Along with the accumulation of the knowledge about miRNAs, the complexity of miRNA-mediated gene regulation is gradually emerging. Discovery of the principles of gene regulation by miRNAs would be helpful in the understanding of their highly complex interactions, and in turn, their biological significance.
###end p 5
###begin p 6
###xml 340 344 340 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000116-John1">[15]</xref>
###xml 346 350 346 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000116-Krek1">[20]</xref>
###xml 352 356 352 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000116-Wang1">[21]</xref>
Some general principles of gene regulation mediated by miRNAs have been predicted by a bioinformatics approach as follows: (1) miRNAs appear to act cooperatively through multiple target sites in one gene by either one or several different miRNAs, and (2) most miRNAs are involved in translational regulation through targeting several genes [15], [20], [21]. However, these principles have yet to be validated. Furthermore, many questions need to be addressed to better understand miRNA-mediated gene regulation, including whether there is competitive action, the opposite of coordinate action, among miRNAs; whether miRNA co-targeted genes can be in functionally related gene groups; whether miRNAs targeting multiple genes could cause unwanted cross-reactions among functionally unrelated genes, and if so, how to avoid these unwanted cross-reactions.
###end p 6
###begin p 7
###xml 435 439 435 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000116-Ferrara1">[22]</xref>
###xml 441 445 441 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000116-Olsson1">[23]</xref>
###xml 549 554 <span type="species:ncbi:9606">human</span>
Since angiogenesis is crucial for a wide variety of physiological and pathological processes including development, wound healing, inflammation, and tumor formation, the regulation of angiogenesis is complex and well controlled. Many molecules have been implicated as positive regulators of angiogenesis. Among them, vascular endothelial growth factor (VEGF) is a pivotal angiogenic factor. Its expression is regulated by many factors [22], [23] but it is not clear whether miRNA is involved in VEGF regulation under hypoxia. In this study, we used human CNE cells (from nasopharyngeal carcinoma) as a model to investigate miRNA-directed regulation of VEGF and other angiogenic factors under hypoxia, and to explore the principles of gene regulation by miRNAs.
###end p 7
###begin title 8
Results
###end title 8
###begin title 9
Computational predictions of putative miRNA regulators of VEGF
###end title 9
###begin p 10
###xml 519 523 519 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000116-Enright1">[12]</xref>
###xml 535 539 535 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000116-Rehmsmeier1">[19]</xref>
###xml 837 845 837 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000116.s001">Table S1</xref>
###xml 994 1001 994 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000116-g001">Fig. 1A</xref>
To investigate whether miRNA is involved in VEGF regulation, we first analyzed miRNA target sites or binding sites in the 3'-untranslated region (3'-UTR) of VEGF and its cognate miRNAs with a bioinformatics approach. Prediction of animal miRNA targets is challenging because there is only a partial pairing of miRNAs with their targets, and the mechanism of miRNA-mediated regulation is poorly understood. To improve the accuracy of binding site prediction, we used three target prediction algorithms, miRanda software [12], RNAhybrid [19], and FindTar, a bioinformatics approach designed in our lab. MiRNAs with binding sites in the VEGF 3'-UTR as predicted by two of the three bioinformatics algorithms were selected as putative regulators of VEGF. In total, 109 binding sites for miRNAs and 96 of their cognate miRNAs were predicted (Table S1). A map of miRNA binding to VEGF 3'-UTR was generated and 2 binding site-condense regions (MBSCR) were observed, including nt160-195 and nt820-860 (Fig. 1A).
###end p 10
###begin p 11
###xml 102 109 102 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000116-g001">Fig. 1B</xref>
###xml 153 160 153 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000116-g001">Fig. 1C</xref>
###xml 280 287 280 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000116-g001">Fig. 1D</xref>
###xml 332 336 320 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000116-Bernhart1">[24]</xref>
###xml 541 548 529 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000116-g001">Fig. 1E</xref>
In nt160-195 MBSCR, we found a special miRNA binding site at nt160-185, which is shared by 12 miRNAs (Fig. 1B). These miRNAs belong to 4 miRNA clusters (Fig. 1C) and the sequences of the seed region in the binding sites on the VEGF 3'-UTR are highly conserved across all mammals (Fig. 1D). We used RNAcofold (approximatelyivo/RNA/) [24] to analyze the secondary structure of the multi-miRNA binding site and its flank regions in the VEGF 3'-UTR and found that the binding sites were located in 'unstable' regions with multi-branching loops (Fig. 1E), characteristic of an important miRNA target site. Although it is common for one mRNA to have multi-miRNA binding sites, the results of the computational prediction still surprised us when so many miRNA binding sites and their cognate miRNAs were found targeting VEGF. We then decided to use CNE cells as a cellular system to investigate how miRNAs regulate VEGF expression.
###end p 11
###begin title 12
miRNA and VEGF Expression in CNE cells
###end title 12
###begin p 13
###xml 187 194 187 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000116.s002">Fig. S1</xref>
###xml 467 471 453 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000116-He3">[25]</xref>
###xml 473 477 459 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000116-Tusher1">[26]</xref>
###xml 623 631 609 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000116-t001">Tables 1</xref>
###xml 633 634 619 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000116-t002">2</xref>
###xml 639 640 625 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000116-t003">3</xref>
###xml 666 775 652 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-16, miR-20a, miR-20b, let-7b, miR-17-5p, miR-27a, miR-106a, miR-106b, miR-107, miR-193a, miR-210, miR-320</italic>
###xml 781 788 767 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-361</italic>
###xml 820 827 806 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MiR-15b</italic>
Total RNA was obtained for miRNA chip analysis from CNE cells both with and without hypoxia induction. The expression profile of microRNAs in CNE cells is provided as supplementary data (Fig. S1). We compared the expression of miRNAs between the two samples and identified 13 miRNAs that were sharply down-regulated and 6 miRNAs that were greatly up-regulated according to microarray analysis, with fold change>/=3 (SAM version 2.1, approximatelytibs/SAM/index.html) [25], [26]. Another 35 miRNAs were also detected in this cellular system, but they did not appear to be differentially expressed between these two samples (Tables 1, 2 and 3). Among these 54 miRNAs, miR-16, miR-20a, miR-20b, let-7b, miR-17-5p, miR-27a, miR-106a, miR-106b, miR-107, miR-193a, miR-210, miR-320, and miR-361 were predicted to target VEGF. MiR-15b was also predicted as a putative miRNA regulator of VEGF by one computational algorithm (FindTar).
###end p 13
###begin p 14
###xml 114 118 114 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000116-Jiang1">[27]</xref>
###xml 313 326 313 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000116-g002">Fig. 2A and B</xref>
###xml 708 732 708 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-15b, miR-16, miR-20a</italic>
###xml 738 745 738 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-20b</italic>
###xml 858 865 858 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000116-g002">Fig. 2C</xref>
As hypoxia is a strong inducer of VEGF, treatment with DFOM, a hypoxia inducer, usually increases VEGF expression [27]. We performed RT-PCR and ELISA assays to determine VEGF expression at the mRNA and protein levels, and found that VEGF was up-regulated in hypoxia-induced CNE cells compared with control cells (Fig. 2A and B). These results were in sharp contrast to the down-regulation of 13 different miRNAs. We hypothesized that some of the miRNAs which were down-regulated in hypoxia-induced CNE cells might unblock VEGF and cause the increase in its expression. In line with this hypothesis, 4 of these 13 down-regulated miRNAs identified by miRNA chip assays were predicted to target VEGF. These are miR-15b, miR-16, miR-20a, and miR-20b. Down-regulation of these 4 miRNAs in hypoxia-induced CNE cells was confirmed by an miRNA-detecting experiment (Fig. 2C).
###end p 14
###begin title 15
Validation of the repressive effect of miRNA regulators on VEGF expression
###end title 15
###begin p 16
###xml 39 63 39 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-15b, miR-16, miR-20a</italic>
###xml 69 76 69 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-20b</italic>
###xml 234 258 234 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-15b, miR-16, miR-20a</italic>
###xml 264 271 264 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-20b</italic>
###xml 435 442 435 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-224</italic>
###xml 452 458 452 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-16</italic>
###xml 460 467 460 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-16M</italic>
###xml 503 520 503 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-20a, miR-20aM</italic>
###xml 578 585 578 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MiR-224</italic>
###xml 730 754 730 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-15b, miR-16, miR-20a</italic>
###xml 760 767 760 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-20b</italic>
###xml 894 901 894 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000116-g003">Fig. 3A</xref>
To investigate the putative effects of miR-15b, miR-16, miR-20a, and miR-20b, we determined the consequence of over-expressing these miRNAs on VEGF expression. Hypoxia-induced CNE cells, which expressed high levels of VEGF but lacked miR-15b, miR-16, miR-20a, and miR-20b, were transfected with synthetic miRNA duplexes of these miRNAs and a set of controls. These include one positive control, VEGF-siRNA, and four negative controls, miR-224, mutated miR-16 (miR-16M 5'-UAGCCUAACGUAAAUAUUGGCG- 3') and miR-20a, miR-20aM 5' -UACGUUGCUUAUAGUGCAGGUAG- 3'), and a random sequence. MiR-224 was chosen as one of the negative controls because it was down-regulated during hypoxia but was not predicted to target VEGF. Transfection with miR-15b, miR-16, miR-20a, and miR-20b, but not the negative controls, resulted in a 26-51% decrease in VEGF expression at the protein level 30h after transfection (Fig. 3A).
###end p 16
###begin p 17
###xml 53 77 53 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-15b, miR-16, miR-20a</italic>
###xml 83 90 83 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-20b</italic>
###xml 276 300 276 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-15b, miR-16, miR-20a</italic>
###xml 306 313 306 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-20b</italic>
###xml 390 397 390 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000116-g003">Fig. 3B</xref>
We also analyzed the effect of inhibiting endogenous miR-15b, miR-16, miR-20a, and miR-20b on VEGF expression. Using the same transfection method, we introduced inhibitors of these miRNAs into normoxic CNE cells, which express low levels of VEGF and high levels of endogenous miR-15b, miR-16, miR-20a, and miR-20b. As we expected, VEGF expression measured by ELISA increased significantly (Fig. 3B).
###end p 17
###begin p 18
###xml 438 475 438 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-20a, miR-20b, miR-17-5p, miR-106a</italic>
###xml 481 489 481 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-106b</italic>
###xml 591 626 591 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-15b, miR-16, miR-17-5p, miR-20b</italic>
###xml 632 639 632 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-107</italic>
###xml 711 718 711 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000116-t004">Table 4</xref>
###xml 755 771 755 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-29b, miR-150</italic>
###xml 777 784 777 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-383</italic>
###xml 950 957 950 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-29b</italic>
###xml 962 969 962 969 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 1016 1023 1016 1023 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-29b</italic>
###xml 1028 1035 1028 1035 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-383</italic>
###xml 1423 1436 1423 1436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000116-g004">Fig. 4A and B</xref>
To demonstrate a direct interaction between the 3'-UTR of VEGF with candidate miRNAs, we inserted two fragments of the VEGF 3'-UTR predicted to interact with these miRNAs into a luciferase expression vector to generate luciferase reporter constructs. Construct I contained a fragment located in nt31-216 of the VEGF 3'-UTR, while Construct II contained a fragment in nt703-944 of the VEGF 3'-UTR. Computational predictions indicated that miR-20a, miR-20b, miR-17-5p, miR-106a, and miR-106b had binding sites in Construct I. With slightly relaxed criteria about free energy and conservation, miR-15b, miR-16, miR-17-5p, miR-20b, and miR-107 have computationally predicted target sites in Construct II reporters (Table 4). In addition to a random sequence, miR-29b, miR-150, and miR-383 were employed as negative controls. All three of these miRNAs have putative binding sites predicted by one at least of the three algorithms on the 3'UTR of VEGF but miR-29b and miR-150 do not have binding sites on Construct I, and miR-29b and miR-383 have no binding sites on Construct II. These miRNAs were co-transfected with their respective reporters into COS-7 cells and the levels of luciferase activity were measured to determine the repressive effects of these miRNAs. The dual-luciferase activity assays revealed a repression of 32-68% of luciferase activity compared to the controls, which showed a repression of less than 15% (Fig. 4A and B).
###end p 18
###begin title 19
Combinatorial regulation by miRNAs
###end title 19
###begin p 20
###xml 340 347 340 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-20a</italic>
###xml 353 361 353 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-106b</italic>
###xml 402 409 402 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-20a</italic>
###xml 415 422 415 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-361</italic>
###xml 499 516 499 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-20a, miR-106b</italic>
###xml 521 528 521 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-361</italic>
###xml 549 556 549 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-20a</italic>
###xml 562 569 562 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-361</italic>
###xml 668 675 668 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000116-g005">Fig. 5A</xref>
###xml 766 773 766 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-20a</italic>
###xml 778 786 778 786 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-106b</italic>
###xml 1105 1109 1105 1109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000116-Krek1">[20]</xref>
We have shown that VEGF expression is regulated by multiple miRNAs. Some miRNAs shared a common binding site, whereas other miRNAs have their own binding sites in the 3'-UTR of VEGF. To investigate whether different combinations of miRNAs have different contributions towards VEGF regulation, we performed co-transfection experiments using miR-20a with miR-106b, which share the same binding site, and miR-20a with miR-361, which target their own binding sites. Compared to single transfection with miR-20a, miR-106b, or miR-361, co-transfection of miR-20a with miR-361 exhibited additive repression on VEGF expression, suggesting a coordinate action of these miRNAs (Fig. 5A). On the other hand, little difference was observed between co-transfection of cells with miR-20a and miR-106b. These results suggest that different miRNA combination patterns can produce coordinate action, which increases the repressive effect of miRNAs on VEGF translation, or competitive action, which failed to generate further repression of VEGF translation. The result of coordinate action is consistent with Krek's report [20].
###end p 20
###begin p 21
###xml 358 366 358 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-378,</italic>
###xml 408 434 408 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-93, miR-125a, miR-302d</italic>
###xml 440 447 440 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-373</italic>
###xml 535 542 535 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000116-g005">Fig. 5B</xref>
###xml 680 706 680 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-93, miR-125a, miR-302d</italic>
###xml 711 718 711 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-373</italic>
###xml 728 735 728 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-378</italic>
###xml 737 744 737 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000116-g005">Fig. 5C</xref>
###xml 792 799 792 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-378</italic>
###xml 908 916 908 916 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-125a</italic>
###xml 957 964 957 964 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-378</italic>
###xml 993 1001 993 1001 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-125a</italic>
Competitive action among miRNAs can weaken the total repressive power of an miRNA group. We observed this effect when miRNAs already validated as true regulators of VEGF were co-transfected with an miRNA validated as a false positive regulator. In luciferase reporter Construct II, the inserted fragment of VEGF 3'-UTR contains 1 putative targeting site for miR-378, located at nt842-864. Four other miRNAs (miR-93, miR-125a, miR-302d, and miR-373) also targeted this region. The binding sites of these 5 miRNAs overlapped each other (Fig. 5B). In luciferase activity assays, a significant repressive effect was detected when COS-7 cells were co-transfected with Construct II and miR-93, miR-125a, miR-302d, or miR-373, but not miR-378 (Fig. 5C). However, when cells were co-transfected with miR-378 and one of these four miRNAs, the repressive effect of these miRNAs decreased significantly. In the case of miR-125a, which shares the same seed region with miR-378, the repressive activity of miR-125a was abolished completely, suggesting a competitive interaction between these two miRNAs. Our results also suggest that some of the false positive miRNAs of a gene may be involved in miRNA-mediated gene regulation through competitive action. This may be useful to prevent over-repression of functional miRNAs.
###end p 21
###begin title 22
###xml 24 48 24 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-15b, miR-16, miR-20a</italic>
###xml 54 61 54 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-20b</italic>
Co-regulatory effect of miR-15b, miR-16, miR-20a, and miR-20b on angiogenic factors in CNE cells
###end title 22
###begin p 23
###xml 157 161 157 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000116-Ferrara1">[22]</xref>
###xml 163 167 163 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000116-Olsson1">[23]</xref>
When under hypoxia stimulation, VEGF is not the only angiogenic gene up-regulated, as other angiogenic factors have been reported to be up-regulated as well [22], [23]. Usually, these factors cooperate together resulting in angiogenesis. We hypothesize that there must be common regulatory mechanism(s) to modulate multiple factors involved in angiogenesis. MiRNAs with multiple targets are able to serve the purpose of co-regulating a group of functionally related genes, such as multiple angiogenic factors under strict spacio-temporal conditions.
###end p 23
###begin p 24
###xml 228 264 228 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGF, c-MET, COX2, uPAR, PAI1, MAPK7</italic>
###xml 270 273 270 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ang</italic>
###xml 360 367 360 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-15b</italic>
###xml 372 378 372 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-16</italic>
###xml 430 440 430 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">uPAR, COX2</italic>
###xml 446 451 446 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c-MET</italic>
###xml 468 481 468 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGF. MiR-20a</italic>
###xml 486 493 486 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-20b</italic>
###xml 505 510 505 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c-MET</italic>
###xml 520 527 520 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-20b</italic>
###xml 541 545 541 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COX2</italic>
###xml 877 887 877 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">uPAR, COX2</italic>
###xml 893 907 893 907 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c-MET. MiR-15b</italic>
###xml 912 918 912 918 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-16</italic>
###xml 934 938 934 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">uPAR</italic>
###xml 1068 1072 1068 1072 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">uPAR</italic>
###xml 1088 1095 1088 1095 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-15b</italic>
###xml 1100 1106 1100 1106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-16</italic>
###xml 1108 1115 1108 1115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000116-g006">Fig. 6A</xref>
###xml 1136 1140 1136 1140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COX2</italic>
###xml 1163 1178 1163 1178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-15b, miR-16</italic>
###xml 1184 1191 1184 1191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-20b</italic>
###xml 1197 1202 1197 1202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c-MET</italic>
###xml 1256 1263 1256 1263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-20a</italic>
###xml 1340 1352 1340 1352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000116-g006">Fig 6B and C</xref>
###xml 1471 1474 1471 1474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTN</italic>
###xml 1513 1516 1513 1516 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTN</italic>
###xml 1619 1626 1619 1626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-15b</italic>
###xml 1630 1636 1630 1636 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-16</italic>
###xml 1662 1665 1662 1665 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTN</italic>
###xml 1738 1745 1738 1745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000116-g006">Fig. 6D</xref>
###xml 1783 1790 1783 1790 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-15b</italic>
###xml 1795 1801 1795 1801 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-16</italic>
###xml 1818 1825 1818 1825 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-15b</italic>
###xml 1830 1836 1830 1836 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-16</italic>
###xml 1873 1876 1873 1876 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTN</italic>
###xml 1939 1942 1939 1942 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTN</italic>
###xml 1958 1965 1958 1965 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-15b</italic>
###xml 1970 1976 1970 1976 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-16</italic>
###xml 2017 2020 2017 2020 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTN</italic>
###xml 2075 2082 2075 2082 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-15b</italic>
###xml 2086 2092 2086 2092 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-16</italic>
###xml 2197 2200 2197 2200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTN</italic>
###xml 2311 2335 2311 2335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-15b, miR-16, miR-20a</italic>
###xml 2341 2348 2341 2348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-20b</italic>
To test our hypothesis, we identified the angiogenic factors which are differentially expressed in hypoxia induced CNE cells. In our previous assays of gene expression profiling in CNE cells, 7 of 40 angiogenesis-related genes, VEGF, c-MET, COX2, uPAR, PAI1, MAPK7, and Ang were up-regulated when CNE cells were treated with DFOM. With computational analysis, miR-15b and miR-16 were predicted to be putative regulatory miRNAs of uPAR, COX2, and c-MET, in addition to VEGF. MiR-20a and miR-20b may target c-MET, whereas miR-20b also targets COX2. We further investigated whether these angiogenic factors are co-regulated by these miRNAs, which have been validated as regulators of VEGF in CNE cells. CNE cells were transfected with these miRNAs and with reporter vectors, Construct I, Construct II, and pRL-TK. Western blotting was used to measure protein expression levels of uPAR, COX2, and c-MET. MiR-15b and miR-16 down-regulated uPAR, whereas Construct II up-regulated its expression. It is probable that the fragment of VEGF 3'-UTR in Construct II competed with uPAR for endogenous miR-15b and miR-16 (Fig. 6A). The expression of COX2 was down-regulated by miR-15b, miR-16, and miR-20b, and c-MET was down-regulated by all three of these miRNAs plus miR-20a. Both of these two genes were up-regulated by Construct I and Construct II (Fig 6B and C). To examine the specificity of these miRNAs in the regulation of angiogenic factors expressed in CNE cells, we chose PTN (Pleiotrophin) as a negative control. PTN is an angiogenic factor known to change during hypoxia, but is not predicted to be a target of either miR-15b or miR-16. First we confirmed that PTN expression was up-regulated by the stimulation of hypoxia in CNE cells (Fig. 6D). Then we transfected CNE cells with miR-15b and miR-16, and found that miR-15b and miR-16 did not have a repressive effect on PTN expression. Furthermore, we used Construct II to compete with PTN for endogenous miR-15b and miR-16, but Construct II could not up-regulate PTN expression. This was expected, as no binding site for miR-15b or miR-16 was detected by either the miRanda software, RNAhybrid, or FindTar algorithms in the 3'-UTR fragment of PTN. These data indicate that some of angiogenic factors expressed in CNE cells were specifically co-regulated by miR-15b, miR-16, miR-20a, and miR-20b.
###end p 24
###begin title 25
Discussion
###end title 25
###begin title 26
Possible mechanisms for changes in miRNA levels during hypoxia in CNE cells
###end title 26
###begin p 27
###xml 37 61 37 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-15b, miR-16, miR-20a</italic>
###xml 67 74 67 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-20b</italic>
###xml 475 479 475 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000116-Graeber1">[28]</xref>
###xml 481 485 481 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000116-Koumenis1">[29]</xref>
###xml 597 604 597 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-15b</italic>
###xml 715 722 715 722 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-15b</italic>
###xml 732 736 732 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000116-Xi1">[30]</xref>
###xml 777 784 777 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-15b</italic>
###xml 832 839 832 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-15b</italic>
###xml 855 861 855 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-16</italic>
###xml 876 884 876 884 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-16-2</italic>
###xml 939 946 939 946 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-15b</italic>
###xml 975 981 975 981 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-16</italic>
###xml 1032 1039 1032 1039 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-15b</italic>
###xml 1056 1063 1056 1063 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-15b</italic>
###xml 1068 1074 1068 1074 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-16</italic>
###xml 1099 1106 1099 1106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-20a</italic>
###xml 1111 1118 1111 1118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-20b</italic>
###xml 1388 1392 1372 1376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000116-Giaccia1">[31]</xref>
###xml 1394 1398 1378 1382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000116-Koshiji1">[32]</xref>
###xml 1429 1436 1413 1420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-20a</italic>
###xml 1441 1448 1425 1432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-20b</italic>
###xml 1461 1468 1445 1452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-20a</italic>
###xml 1473 1480 1457 1464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-20b</italic>
###xml 1530 1536 1514 1520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-17</italic>
###xml 1589 1596 1573 1580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-20a</italic>
###xml 1649 1655 1633 1639 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-17</italic>
###xml 1688 1695 1672 1679 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-20b</italic>
###xml 1713 1721 1697 1705 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-106a</italic>
###xml 1866 1874 1850 1858 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-106a</italic>
###xml 1990 1994 1974 1978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000116-ODonnell1">[33]</xref>
###xml 2035 2059 2019 2043 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-15b, miR-16, miR-20a</italic>
###xml 2065 2072 2049 2056 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-20b</italic>
In this investigation, we found that miR-15b, miR-16, miR-20a, and miR-20b are sharply down-regulated in CNE cells after hypoxia treatment. The mechanisms for these changes are not clear; however, we might find some clues from changes in transcription factors during hypoxia. The tumor suppressor gene p53 might be one of the critical factors which cause the changes in miRNA levels during hypoxia. Previous studies indicate that hypoxia could induce the accumulation of p53 [28], [29], and it is possible that the accumulation of p53 may regulate the expression of several miRNAs. As an example, miR-15b was down-regulated significantly in hypoxic conditions. While no p53-binding sites have been predicted in the miR-15b promoter [30], it is possible that p53 down-regulates miR-15b expression through an indirect way. Since both miR-15b and one of two miR-16 genomic loci, miR-16-2, are located in the same cluster on chromosome 3 (the miR-15b cluster), the expression of miR-16 may be regulated by the same mechanism as that of miR-15b. In contrast to miR-15b and miR-16, the down-regulation of miR-20a and miR-20b may be related to hypoxia inducible factor-1alpha (HIF-1alpha). In response to hypoxia, HIF-1alpha becomes stabilized and able to counteract c-Myc functionally. In keeping with its antagonism of Myc, HIF-1alpha down-regulates c-Myc-activated genes such as hTERT, BRCA1 [31], [32], and might also down-regulate miR-20a and miR-20b, since both miR-20a and miR-20b may be c-Myc-activated genes. As a member of the miR-17 cluster located on chromosome 13, the expression of miR-20a is regulated by c-Myc through direct binding to the miR-17 cluster locus. Up-regulation of miR-20b, a member of the miR-106a cluster located on X chromosome, was also consistently observed in the high c-Myc state and seven putative binding sites in the vicinity of the miR-106a cluster were also identified even though no direct binding between c-Myc and these binding sites has been reported [33]. Taken together, the down-regulation of miR-15b, miR-16, miR-20a, and miR-20b in CNE cells might be mediated by the accumulation of p53 or the stabilization of HIF-1alpha during hypoxia.
###end p 27
###begin title 28
Principles of gene regulation by miRNA
###end title 28
###begin p 29
###xml 241 245 241 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000116-John1">[15]</xref>
###xml 247 251 247 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000116-Krek1">[20]</xref>
###xml 253 257 253 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000116-Wang1">[21]</xref>
Initial data released by this investigation first reported miRNA-directed VEGF regulation. Through analysis of this data, we uncovered some new principles of gene regulation by miRNA and also further validated principles predicted by others [15], [20], [21] using experimental methods. The biological significance of these principles was also addressed in this investigation.
###end p 29
###begin p 30
###xml 54 58 54 58 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000116-John1">[15]</xref>
###xml 181 185 181 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000116-Krek1">[20]</xref>
The first is the coordinate principle. John and Marks [15] proposed that miRNAs may act cooperatively through multiple target sites in one gene. Krek's report proved this principle [20] and our results further indicate that miRNAs with independent binding sites in a gene can produce coordinate action, which increases the repressive effect of miRNAs on translation of this gene.
###end p 30
###begin p 31
The second is the co-regulatory principle. It is a common phenomenon that groups of functionally related genes act together to regulate a physiologically related function (e.g. angiogenesis). It therefore appears as if a common regulatory mechanism controls the multiple factors involved in these functions. MiRNA with the ability to target multiple genes could potentially regulate a group of functionally related genes. In this study, we determined that some miRNAs identified as VEGF regulators also regulated the expression of other angiogenic factors. We call this regulatory pattern a co-regulatory principle, meaning that one or a few miRNAs can co-regulate a group of functionally related genes. This is a convenient and efficient regulatory pattern but may cause unwanted cross-reaction between genes, if an miRNA is expressed for regulating one gene, but also targets other genes which need not be repressed under the same conditions. Therefore, there must be some mechanisms to prevent unwanted cross-reactions.
###end p 31
###begin p 32
###xml 607 611 607 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000116-Barad1">[34]</xref>
###xml 635 639 635 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000116-Jiang2">[35]</xref>
###xml 950 957 950 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000116-t005">Table 5</xref>
###xml 1284 1288 1284 1288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000116-Ferrara1">[22]</xref>
###xml 1290 1294 1290 1294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000116-Olsson1">[23]</xref>
The third is the principle of differential regulation. As an miRNA-targeted gene, VEGF might be regulated by many miRNAs, according to the number of binding sites in its 3'-UTR. However, only some of these miRNAs are involved in VEGF regulation or VEGF maintenance in CNE cells. The others might be reserved for the needs of other cells under different conditions. To ensure that VEGF expression is regulated by distinct miRNAs in different cells under different conditions, we analyzed the relationship between VEGF expression and the miRNA expression profile in five VEGF-expressing cell lines: CNE, HeLa [34], MCF-7, HL60, and K562 [35]. In these cell lines, 31-104 miRNAs were detected and 9-31 of those miRNAs were predicted as putative regulators of VEGF. Through comparison of these five cell lines, we found that not only does each cell line express different numbers of miRNAs, they also employ discrete combinations of VEGF-related miRNAs (Table 5). Since angiogenesis is crucial for a wide variety of physiological and pathological processes including development, wound healing, inflammation, and tumor formation, many molecules have been implicated as positive regulators of angiogenesis. Being a pivotal factor, VEGF expression is complex and needs to be well regulated [22], [23]. Various miRNA binding sites provide a number of choices which not only meet different needs under various processes but also avoid unwanted cross-reactions. We call this pattern differential regulation, which means that a gene with multiple binding sites for a number of miRNAs can be regulated by discrete miRNAs in differing cells under different conditions. However, the pattern of differential regulation may not be enough to prevent unwanted cross-reactions between genes, since some miRNAs have too many target genes.
###end p 32
###begin p 33
###xml 766 803 766 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-17-5p, miR-20a, miR-20b, miR-106a</italic>
###xml 809 817 809 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-106b</italic>
###xml 883 890 883 890 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-20a</italic>
###xml 895 902 895 902 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-20b</italic>
Competitive action was recognized as the final principle of gene regulation by miRNAs, and it can be seen when multiple miRNAs compete with each other for a common binding site (called a multi-miRNA binding site) or a functional miRNA competes with a false positive miRNA for the same binding site. The biological role of competitive action is not very clear. It might be related to prevention of unwanted cross-reactions between genes. In this investigation, we found a multi-miRNA binding site located in nt162-185 of the VEGF 3'-UTR, which functioned as a specially designed ruse for the prevention of unwanted cross-reactions between miRNA-targeting genes. This binding site is shared by 12 different miRNAs, according to the bioinformatics prediction, but only miR-17-5p, miR-20a, miR-20b, miR-106a, and miR-106b were detected in DFOM-untreated CNE cells. Among these 5 miRNAs, miR-20a and miR-20b were validated as regulatory miRNAs in hypoxia-induced VEGF expression, whereas the other three could be expressed for the regulation of other genes without over-repressing VEGF expression due to competitive action. Thus, the unwanted cross-reaction of VEGF with other genes could be prevented. In some circumstances, if VEGF expression needs no repression, but some regulatory miRNAs of VEGF are expressed for regulation of other genes, the unwanted cross-reaction of VEGF can be decreased through the expression of false positive miRNAs to compete with the functionally effective miRNAs. The competitive principle, differential regulation, multi-miRNA binding sites, and false positive miRNAs might be useful strategies to avoid unwanted cross actions between targeting genes of miRNAs with multiple targets. The patterns of miRNA-directed VEGF regulation demonstrate several principles of miRNA-mediated gene regulation, and these principles will be helpful for us to understand the highly complex pattern of gene regulation by miRNAs.
###end p 33
###begin title 34
Some concerns about negative control miRNAs
###end title 34
###begin p 35
###xml 146 154 146 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-106a</italic>
###xml 159 167 159 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-106b</italic>
###xml 207 214 207 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-15b</italic>
###xml 219 225 219 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-16</italic>
###xml 664 671 664 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-15b</italic>
###xml 676 682 676 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-16</italic>
###xml 702 710 702 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-106a</italic>
###xml 715 723 715 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-106b</italic>
###xml 1232 1239 1232 1239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-15b</italic>
###xml 1244 1250 1244 1250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-16</italic>
###xml 1270 1278 1270 1278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-106a</italic>
###xml 1283 1291 1283 1291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-106b</italic>
###xml 1373 1389 1373 1389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-29b, miR-150</italic>
###xml 1395 1402 1395 1402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-383</italic>
###xml 1607 1623 1607 1623 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-29b, miR-150</italic>
###xml 1629 1636 1629 1636 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-383</italic>
To test the specificity of prediction of miRNA target sites, we first did experiments with a luciferase activity assay to test: a) the effects of miR-106a and miR-106b on Construct II; and b) the effects of miR-15b and miR-16 on Construct I. We found that all of these miRNAs showed repression of 20-27% of luciferase activity. The criteria that we used to predict miRNA targets of VEGF in this investigation are: only the binding sites predicted by two of the three bioinformatics algorithms, miRanda software, RNAhybrid, and FindTar algorithm, were selected as putative binding sites for miRNA in the VEGF 3'-UTR. According to the criteria, no binding sites for miR-15b and miR-16 on Construct I and miR-106a and miR-106b on Construct II were found. However, the result of the luciferase activity assay suggests that this is a false negtive prediction. Combinative use of more than one computational algorithm in the prediction of miRNA binding sites could decrease the false positive rate, but it might increase the false negtive rate because the overlap between computational algorithms is not very good. When the prediction was carried out with miRanda software, RNAhybrid, and FindTar algorithms separately, binding sites for miR-15b and miR-16 on Construct I and miR-106a and miR-106b on Construct II would be detected by one of these algorithms. We therefore chose miR-29b, miR-150, and miR-383, which have putative binding sites on the 3'-UTR of VEGF but do not have putative binding sites on Construct I or II, as predicted by all of the three algorithms, to test the specificity. As we expected, miR-29b, miR-150, and miR-383 did not show repressive effects on Construct I or II. Our results suggest that it is important to confirm that an miRNA is not a potential regulatory miRNA of a specific gene by using different bioinformatics algorithms before using the miRNA as a negative control.
###end p 35
###begin title 36
Materials and Methods
###end title 36
###begin title 37
Cell culture and hypoxia inducement
###end title 37
###begin p 38
###xml 187 188 181 182 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 13 18 <span type="species:ncbi:9606">human</span>
CNE cells, a human nasopharyngeal carcinoma cell line, were obtained from Kunming Cell Bank (Kunming, China) and maintained in RPMI 1640 medium containing 10% FBS at 37degreesC with 5% CO2. Hypoxia inducement was carried out with DFOM (Sigma-Aldrich Co., MO, USA) at a final concentration of 130 uM and cells without DFOM treatment were used as control. After 20 hours of DFOM treatment, the cells were harvested and total RNA was isolated with TRIzol Reagent (Invitrogen Corp. CA) according to the manufacturer's protocol.
###end p 38
###begin title 39
RNA preparation, miRNA microarray experiments, and miRNA detection
###end title 39
###begin p 40
###xml 332 336 328 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000116-Thomson1">[36]</xref>
###xml 610 614 606 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000116-Xie1">[37]</xref>
###xml 893 897 889 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000116-He3">[25]</xref>
###xml 899 903 895 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000116-Tusher1">[26]</xref>
###xml 987 990 983 986 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mir</italic>
###xml 453 458 <span type="species:ncbi:9606">human</span>
###xml 497 502 <span type="species:ncbi:10090">mouse</span>
###xml 512 515 <span type="species:ncbi:10116">rat</span>
Total RNA samples were sent to CapitalBio (CapitalBio Corp., Beijing, China) for miRNA microarray experiments. Procedures were performed as described in detail on the website of CapitalBio (). Briefly, 50-100 microg of total RNA were used to extract miRNA using an miRNA Isolation Kit (Ambion Inc. Texas). Fluorescein-labeled miRNA [36] were used for hybridization on each miRNA microarray chip containing 509 probes in triplicate, corresponding to 435 human (including 122 predicted miRNAs), 261 mouse, and 196 rat miRNAs found in the miRNA Registry (; accessed Oct. 2005) or collected from a published paper [37]. Raw data were normalized and analyzed in GenePix Pro 4.0 software (Axon Instruments, PA, USA). Expression data were median-centered by using the global median normalization of the BIOCONDUCTOR package (). Statistical comparisons were done with SAM software (SAM version 2.1, ) [25], [26]. The microarray data were confirmed through an miRNA detection experiment with the mirVanatrade mark miRNA detection kit (Ambion Inc. Texas).
###end p 40
###begin title 41
Cell transfection with miRNAs or miRNA inhibitors
###end title 41
###begin p 42
###xml 392 396 392 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000116-Takei1">[38]</xref>
SiRNA duplexes homologous in sequence to miRNA and their inhibitors were synthesized and purified by Shanghai GenePharma Co. (Shanghai, China). The sequences of these inhibitors are the exact antisense copy of the mature miRNAs and all the nucleotides in the inhibitors contain 2'-OMe modifications at each base. A VEGF siRNA which targets mRNA sequence 5'-GGAGUACCCUGAUGAGAUC-3' (nt189-207) [38] was used as a positive control (PC). SiRNA duplexes with non-specific sequences were used as a negative control (NC).
###end p 42
###begin p 43
MiRNA duplexes or their inhibitors were transfected into CNE cells using the transfection protocol recommended by Invitrogen. In brief, CNE cells were seeded into 96 or 24 well plates one day prior to transfection. When the cells reached 50-70% confluence, miRNA duplexes or their inhibitors were transfected into the cells at a concentration of 4 or 6 pmol/well for the 96 well plates, and 20 or 30 pmol/well for the 24 well plates, using the Lipofectamine 2000 reagent (Invitrogen Corp. CA, USA). Hypoxia induction was carried out using the method described before. The same amount of negative control RNA duplexes and VEGF siRNA were also transfected. The cell lysate and culture medium were collected 30 hr post-transfection.
###end p 43
###begin title 44
Assay of luciferase activity
###end title 44
###begin p 45
###xml 1095 1102 1095 1102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 1274 1278 1274 1278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000116-Stark1">[14]</xref>
To perform luciferase activity assays, VEGF 3'-UTR (nt163-184) and its flank sequence was PCR-amplified using two primers, 5'-CGTTCTAGAGTTTCGGGA ACCAGATCTC-3' and 5'-AACACTAGTAATGCTTCCGCCGGAGT-3'. Two copies of the target sequence were cloned downstream of the stop codon in pRL-TK (Promega Corp. WI, USA). The other sequence which contains multiple binding sites in VEGF 3'-UTR (nt700-850) was also amplified using two primers, 5'- TCTTCTAGACAGGTCAGACGGACAG-3' and 5'-ACAACTAGTCTCTTCTCTTCGCCGG-3', and two copies of the target sequence were cloned downstream of the stop codon in pRL-TK. We pre-plated COS-7 or CNE cells 24 h prior to transfection in 24-well tissue culture plates. The next day COS-7 or CNE cells were transfected with 100 or 400 ng of pRL-TK (Rr-luc) and 5 or 100 ng of pGL3 control vector (Pp-luc, from Promega Corp. WI, USA). For the co-transfection of miRNAs or their inhibitors with reporter vectors, 20 nM of each miRNA duplex or 30 nM of each inhibitor was transfected using Lipofectamine 2000. Cell lysate was collected and assayed 30 h after transfection. Firefly and Renilla luciferase activities were measured using a Dual Luciferase Reporter Assay System (Promega Corp. WI, USA) and each transfected well was assayed in triplicate as described [14].
###end p 45
###begin title 46
ELISA assays
###end title 46
###begin p 47
The culture medium of CNE cells was recovered for ELISA assays using VEGF ELISA from R & D systems (Minneapolis, MN) and a GENios ELISA plate reader (TECAN, Austria). All experiments were repeated four times.
###end p 47
###begin title 48
Western blots
###end title 48
###begin p 49
###xml 413 417 413 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000116-Wu2">[39]</xref>
Cell supernatant or cell lysate was subjected to SDS-PAGE and transferred to a nitrocellulose membrane. Protein expression was analyzed by Western blotting with primary antibodies against uPAR, COX2, c-MET, and PTN (Santa Cruz, California) and then incubated with a secondary antibody. After washing, the bound antibody was visualized with an ECL kit (Amersham Pharmacia Biotech, NJ, USA) as described previously [39].
###end p 49
###begin title 50
RT-PCR
###end title 50
###begin p 51
Total RNA was isolated with TRIzol Reagent (Invitrogen, Gaithersburg, MD) according to the manufacturer's protocol. RT-PCR was performed with the total RNA using TaKaRa one step RNA PCR kit (TaKaRa Bio Inc, Japan). The VEGF expression level was detected with a pair of primers, forward: 5'-GAGGGCAGAATCATCACGAA-3'; reverse: 5'-GGGAACGCTCCAGGACTTAT-3'. The gene expression level of VEGF was normalized against a housekeeping gene, glyceraldehyde-3-phosphate dehydrogenase (GADPH).
###end p 51
###begin title 52
Bioinformatics
###end title 52
###begin p 53
###xml 106 110 106 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000116-Enright1">[12]</xref>
###xml 125 129 125 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000116-Rehmsmeier1">[19]</xref>
miRNA target site prediction of VEGF and other angiogenic factors was performed by using miRanda software [12] (), RNAhybrid [19] (), and FindTar algorithm, a bioinformatics approach designed by us. MiRanda was used for the primary screening of miRNA target sites with cut-off values for free energy (DeltaG)<-14 kcal/mole and scores>70, and the FindTar algorithm for secondary screening with a criteria of (DeltaG)<-20 kcal/mole, and high conservation among mammals. The program was run with a temperature setting at 37degreesC.
###end p 53
###begin title 54
3'-UTR Datasets and MicroRNA Datasets
###end title 54
###begin p 55
###xml 65 77 65 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Homo sapiens</italic>
###xml 87 99 87 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mus musculus</italic>
###xml 107 124 107 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rattus norvegicus</italic>
###xml 139 154 139 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pan troglodytes</italic>
###xml 166 176 166 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bos taurus</italic>
###xml 270 274 270 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000116-GriffithsJones1">[40]</xref>
###xml 58 63 <span type="species:ncbi:9606">human</span>
###xml 65 77 <span type="species:ncbi:9606">Homo sapiens</span>
###xml 80 85 <span type="species:ncbi:10090">mouse</span>
###xml 87 99 <span type="species:ncbi:10090">Mus musculus</span>
###xml 102 105 <span type="species:ncbi:10116">rat</span>
###xml 107 124 <span type="species:ncbi:10116">Rattus norvegicus</span>
###xml 127 137 <span type="species:ncbi:9598">chimpanzee</span>
###xml 139 154 <span type="species:ncbi:9598">Pan troglodytes</span>
###xml 161 164 <span type="species:ncbi:9913">Cow</span>
###xml 166 176 <span type="species:ncbi:9913">Bos taurus</span>
###xml 221 226 <span type="species:ncbi:9606">Human</span>
3' untranslational region (3'-UTR) sequences of VEGF from human (Homo sapiens), mouse (Mus musculus), rat (Rattus norvegicus), chimpanzee (Pan troglodytes), and Cow (Bos taurus) were retrieved using Ensembl Data base (). Human miRNA sequences of the RFAM miRNA registry [40] were downloaded from the miRBase website ().
###end p 55
###begin title 56
The design of FindTar algorithm
###end title 56
###begin p 57
###xml 243 247 243 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000116-Lewis1">[13]</xref>
###xml 249 253 249 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000116-Stark1">[14]</xref>
###xml 255 259 255 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000116-Rajewsky1">[17]</xref>
###xml 356 360 356 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000116-Stark1">[14]</xref>
###xml 362 366 362 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000116-Rajewsky2">[18]</xref>
It was recognized that the nucleus or seed, typically a perfectly Watson-Crick-base-paired stretch of 7 nt starting at either the first or the second base of the microRNA (counted from the 5' end), was the most critical for target recognition [13], [14], [17]. In the design of the FindTar algorithm, we started with experimental results from other groups [14], [18], and used a slightly relaxed seed criterion to search the mRNA sequences for a binding site, so that more potential miRNA targets could be included in the primary screening. Our seed criterion was defined as a perfectly Watson-Crick-base-paired stretch of 6 nt starting at the first, second, or third base of the miRNA, but one G-U wobble in the seed would be tolerable. After the seed regions were identified, we predicted the secondary structure and minimum free energy of the possible miRNA:miRBS (miRBS: miRNA binding site) using RNAcofold software (Vienna RNA Package 1.5 beta version, ). RNAcofold was also incorporated into the FindTar algorithm. Sequences of miRNA binding sites in mRNA, and a given miRNA, were input for precisely predicting the RNA secondary structures of the miRNA/miRBS duplexes and calculating minimum free energy (DeltaG) of the whole miRNA/miRBS duplex.
###end p 57
###begin title 58
Supporting Information
###end title 58
###begin p 59
###xml 85 90 <span type="species:ncbi:9606">human</span>
RNAhybrid, miRanda, and FindTar were used to predict potential binding sites of each human miRNA. The sites found by two or all of these three software were chosen as putative binding sites for miRNAs (all these sites were predicted by FindTar). Free energy is calculated by RNAcofold.
###end p 59
###begin p 60
(0.14 MB DOC)
###end p 60
###begin p 61
Click here for additional data file.
###end p 61
###begin p 62
Image of miRNA microarray. miRNA array analysis was performed with mRNA samples from hypoxia-induced CNE cells (A and B) and non-induced CNE cells (C and D). An miRNA microarray chip containing 509 probes in triplicate was used in the analysis.
###end p 62
###begin p 63
(6.39 MB TIF)
###end p 63
###begin p 64
Click here for additional data file.
###end p 64
###begin title 65
References
###end title 65
###begin article-title 66
MicroRNAs: genomics, biogenesis, mechanism, and function.
###end article-title 66
###begin article-title 67
MicroRNAs: small RNAs with a big role in gene regulation.
###end article-title 67
###begin article-title 68
MicroRNAs direct rapid deadenylation of mRNA.
###end article-title 68
###begin article-title 69
Expanding roles for miRNAs and siRNAs in cell regulation.
###end article-title 69
###begin article-title 70
Functions of microRNAs and related small RNAs in plants.
###end article-title 70
###begin article-title 71
Developmental biology. Encountering microRNAs in cell fate signaling.
###end article-title 71
###begin article-title 72
MicroRNAs and the regulation of cell death.
###end article-title 72
###begin article-title 73
Microarray analysis of microRNA expression in the developing mammalian brain.
###end article-title 73
###begin article-title 74
###xml 38 43 <span type="species:ncbi:9606">human</span>
A microRNA polycistron as a potential human oncogene.
###end article-title 74
###begin article-title 75
The functions of animal microRNAs.
###end article-title 75
###begin article-title 76
RAS is regulated by the let-7 microRNA family.
###end article-title 76
###begin article-title 77
###xml 20 30 <span type="species:ncbi:7227">Drosophila</span>
MicroRNA targets in Drosophila.
###end article-title 77
###begin article-title 78
Prediction of mammalian microRNA targets.
###end article-title 78
###begin article-title 79
###xml 18 28 <span type="species:ncbi:7227">Drosophila</span>
Identification of Drosophila MicroRNA targets.
###end article-title 79
###begin article-title 80
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human MicroRNA targets.
###end article-title 80
###begin article-title 81
###xml 56 61 <span type="species:ncbi:9606">human</span>
A combined computational-experimental approach predicts human microRNA targets.
###end article-title 81
###begin article-title 82
Computational identification of microRNA targets.
###end article-title 82
###begin article-title 83
microRNA target predictions in animals.
###end article-title 83
###begin article-title 84
Fast and effective prediction of microRNA/target duplexes.
###end article-title 84
###begin article-title 85
Combinatorial microRNA target predictions.
###end article-title 85
###begin article-title 86
RNA silencing and antiviral defense in plants.
###end article-title 86
###begin article-title 87
The biology of VEGF and its receptors.
###end article-title 87
###begin article-title 88
VEGF receptor signalling - in control of vascular function.
###end article-title 88
###begin article-title 89
Partition function and base pairing probabilities of RNA heterodimers.
###end article-title 89
###begin article-title 90
The role of microRNA genes in papillary thyroid carcinoma.
###end article-title 90
###begin article-title 91
Significance analysis of microarrays applied to the ionizing radiation response.
###end article-title 91
###begin article-title 92
Transactivation and inhibitory domains of hypoxia-inducible factor 1alpha. Modulation of transcriptional activity by oxygen tension.
###end article-title 92
###begin article-title 93
Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status.
###end article-title 93
###begin article-title 94
Regulation of p53 by hypoxia: dissociation of transcriptional repression and apoptosis from p53-dependent transactivation.
###end article-title 94
###begin article-title 95
Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer.
###end article-title 95
###begin article-title 96
The biology of hypoxia: the role of oxygen sensing in development, normal function, and disease.
###end article-title 96
###begin article-title 97
HIF-1alpha induces cell cycle arrest by functionally counteracting Myc.
###end article-title 97
###begin article-title 98
c-Myc-regulated microRNAs modulate E2F1 expression.
###end article-title 98
###begin article-title 99
###xml 110 115 <span type="species:ncbi:9606">human</span>
MicroRNA expression detected by oligonucleotide microarrays: system establishment and expression profiling in human tissues.
###end article-title 99
###begin article-title 100
###xml 57 62 <span type="species:ncbi:9606">human</span>
Real-time expression profiling of microRNA precursors in human cancer cell lines.
###end article-title 100
###begin article-title 101
A custom microarray platform for analysis of microRNA gene expression.
###end article-title 101
###begin article-title 102
###xml 45 50 <span type="species:ncbi:9606">human</span>
Systematic discovery of regulatory motifs in human promoters and 3' UTRs by comparison of several mammals.
###end article-title 102
###begin article-title 103
A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics.
###end article-title 103
###begin article-title 104
Versican protects cells from oxidative stress-induced apoptosis.
###end article-title 104
###begin article-title 105
The microRNA Registry.
###end article-title 105
###begin title 106
Figures and Tables
###end title 106
###begin title 107
Analysis of miRNA binding sites in VEGF.
###end title 107
###begin p 108
###xml 73 81 73 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000116.s001">Table S1</xref>
(A) The map of miRNA binding sites in the VEGF 3'-UTR in accordance with Table S1. Three bioinformatics algorithms, RNAhybrid, miRanda, and FindTar, were used to predict miRNA binding sites in the VEGF 3'-UTR. A binding site map of the VEGF 3'-UTR was generated with the putative binding sites predicted by at least two bioinformatics algorithms. Subsequently, two miRNA binding site-condense regions (MBSCR) were uncovered, that is, 160-195nt and 820-860nt MBSCR. (B) A common miRNA binding site located in 160-185nt shared by 12 miRNAs. (C) The miRNAs that share this common miRNA binding site belong to four different miRNA clusters. (D) The seed region of this common miRNA binding site is highly conserved among mammals. (E) RNAcofold was used to analyze the secondary structure of the common miRNA binding site and its flank regions in the VEGF 3'-UTR. The common binding site is located in an unstable region with a multi-branching loop-like RNA structure.
###end p 108
###begin title 109
VEGF and miRNA expression in CNE cells.
###end title 109
###begin p 110
###xml 244 247 244 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mir</italic>
###xml 326 350 317 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-15b, miR-16, miR-20a</italic>
###xml 356 363 347 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-20b</italic>
Cell lysate and culture medium from DFOM-induced CNE cells were collected. RT-PCR (A) and ELISA (B) assays were performed to determine VEGF expression at the mRNA and protein levels. CNE cells without DFOM treatment were used as a control. The mirVanatrade mark miRNA Detection procedure was used to validate miRNA chip data. miR-15b, miR-16, miR-20a, and miR-20b were down-regulated in hypoxia induced CNE cells (C). I: induced, N: non-induced.
###end p 110
###begin title 111
Validation of the repressive effect of putative miRNA regulators on VEGF expression in CNE cells.
###end title 111
###begin p 112
###xml 83 107 83 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-15b, miR-16, miR-20a</italic>
###xml 113 120 113 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-20b</italic>
###xml 391 398 391 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-224</italic>
###xml 408 414 408 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-16</italic>
###xml 420 427 420 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-20a</italic>
###xml 429 446 429 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-16M, miR-20aM</italic>
###xml 593 618 593 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> miR-15b, miR-16, miR-20a</italic>
###xml 624 631 624 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-20b</italic>
###xml 761 785 761 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-15b, miR-16, miR-20a</italic>
###xml 791 798 791 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-20b</italic>
(A) Transient overexpression of miRNAs in hypoxia-induced CNE cells. The effect of miR-15b, miR-16, miR-20a, and miR-20b on VEGF expression was tested in CNE cells by transfection of the cells with siRNA duplexes homologous in sequence to the miRNAs. ELISA was used to detect VEGF expression levels. The controls consist of one positive control: VEGF-siRNA (PC), and four negative controls: miR-224, mutated miR-16, and miR-20a (miR-16M, miR-20aM), and a random sequence (NC). (B) Transfection of miRNA inhibitors in hypoxia non-induced CNE cells. CNE cells were transfected with inhibitors of miR-15b, miR-16, miR-20a, and miR-20b. siRNA against VEGF was used as positive control. ELISA was used to detect the change in VEGF expression levels after endogenous miR-15b, miR-16, miR-20a, and miR-20b were inhibited. *, p<0.05; **, p<0.01. NC: negative control; PC: positive control.
###end p 112
###begin title 113
Luciferase activity assay.
###end title 113
###begin p 114
###xml 553 568 553 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-29, miR-150</italic>
###xml 574 581 574 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-383</italic>
Luciferase reporter constructs were generated through placing fragments of 185 bp (Construct I, sequence from nt31-216 of the VEGF 3'-UTR) and 241 bp (Construct II, sequence from nt703-944 of the VEGF 3'-UTR) at the 3' end of luciferase gene in pRL-TK. COS-7 cells were co-transfected with a luciferase reporter vector and an miRNA which has a putative binding site in either Construct I (A) or Construct II (B). Luciferase activity was measured to determine the effects of these miRNAs on luciferase translation. In addition to a random sequence (NC), miR-29, miR-150, and miR-383 which have putative binding sites in the 3'-UTR of VEGF but not on Construct I or II, as predicted by all of the algorithms, were employed as negative controls. *, p<0.05; **, p<0.01.
###end p 114
###begin title 115
Effects of different combinations of miRNAs on VEGF expression.
###end title 115
###begin p 116
###xml 54 61 54 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-20a</italic>
###xml 66 74 66 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-106b</italic>
###xml 119 126 119 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-20a</italic>
###xml 131 138 131 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-361</italic>
###xml 481 516 481 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-378, miR-125a, miR-93, miR-302d</italic>
###xml 522 529 522 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-373</italic>
###xml 637 672 637 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-378, miR-125a, miR-93, miR-302d</italic>
###xml 677 684 677 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-373</italic>
###xml 707 714 707 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-378</italic>
###xml 727 753 727 753 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-125a, miR-93, miR-302d</italic>
###xml 758 765 758 765 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-373</italic>
(A) CNE cells were transfected or co-transfected with miR-20a and miR-106b, which share the same binding site, or with miR-20a and miR-361, which target different binding sites. An unrelated random sequence was used as a negative control (NC). A specific sequence targeting VEGF (functioning as siRNA) was used as a positive control (PC). Culture medium was collected 30h after transfection. Repression of VEGF expression was detected by ELISA. (B) miRNA binding site locations of miR-378, miR-125a, miR-93, miR-302d, and miR-373 in the VEGF 3'-UTR fragment of Construct II. (C) COS-7 cells were co-transfected with (1) Construct II and miR-378, miR-125a, miR-93, miR-302d, or miR-373; (2) Construct II and miR-378 plus either miR-125a, miR-93, miR-302d, or miR-373. Luciferase activity was measured to investigate the effects of different combinations of miRNAs. *, p<0.05; **, p<0.01.
###end p 116
###begin title 117
Co-regulation of miRNAs to angiogenic factors.
###end title 117
###begin p 118
###xml 68 92 68 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-15b, miR-16, miR-20a</italic>
###xml 97 104 97 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-20b</italic>
CNE cells were induced with or without DFOM (6-1), transfected with miR-15b, miR-16, miR-20a, or miR-20b (6-2) and transfected with Construct I or Construct II (6-3). Cell lysate was collected, and the expression of angiogenic factors uPAR (A), COX2 (B), c-MET (C), and PTN (D) were determined by Western Blotting.
###end p 118
###begin title 119
microRNAs down-regulated in DFOM-induced CNE.
###end title 119
###begin p 120
All differentially expressed miRNAs have a q value<0.01 (false-positive rate).
###end p 120
###begin p 121
t test p<0.05.
###end p 121
###begin title 122
microRNAs up-regulated in DFOM-induced CNE.
###end title 122
###begin p 123
All differentially expressed miRNAs have a q value<0.01 (false-positive rate).
###end p 123
###begin p 124
t test p<0.05.
###end p 124
###begin title 125
microRNAs non-differentially expressed in CNE with or without hypoxia treatment.
###end title 125
###begin title 126
miRNA binding sites at fragments of the VEGF 3'-UTR in report vector Construct I or II.
###end title 126
###begin p 127
endogenous miRNAs
###end p 127
###begin title 128
miRNAs which putatively target VEGF and are expressed in CNE, HeLa, MCF7, HL60, and K562.
###end title 128
###begin p 129
"+" indicates those miRNAs which are expressed in a specific cell line and have predictive targets in the 3' untranslated region of VEGF; "-" indicates those miRNAs which are not expressed in a specific cell line; "n/a" indicates that the miRNA is not within the detection range in certain experimental approaches; "V-miRNAs" means miRNAs targeting VEGF; T-miRNAs means total miRNAs which are expressed in the cell lines.
###end p 129
###begin p 130
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 130
###begin p 131
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by a China-Canada Joint Health Research Initiative grant from the National Natural Science Foundation of China (Grant No. 30611120519) and Canadian Institutes of Health Research to Yaou Zhang and Burton B. Yang, and Grant MOP-62729 from Canadian Institutes of Health Research to Burton B. Yang.
###end p 131

